Article Type
Changed
Fri, 09/30/2022 - 21:33

Key clinical point: Statin exposure reduces the risk for and improves the prognosis of gastric cancer.

Major finding: The statin-exposed vs -nonexposed population showed a significantly reduced incidence (odds ratio [OR] 0.78; P < .001) and improved prognosis (OR 0.78; P = .002) of gastric cancer.

Study details: This was a meta-analysis of 19 studies that analyzed the correlation between statin exposure and the occurrence and progression of gastric cancer.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Lou D et al. Association between statins' exposure with incidence and prognosis of gastric cancer: An updated meta-analysis. Expert Rev Clin Pharmacol. 2022; 1-12 (Aug 15). Doi: 10.1080/17512433.2022.2112178

Publications
Topics
Sections

Key clinical point: Statin exposure reduces the risk for and improves the prognosis of gastric cancer.

Major finding: The statin-exposed vs -nonexposed population showed a significantly reduced incidence (odds ratio [OR] 0.78; P < .001) and improved prognosis (OR 0.78; P = .002) of gastric cancer.

Study details: This was a meta-analysis of 19 studies that analyzed the correlation between statin exposure and the occurrence and progression of gastric cancer.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Lou D et al. Association between statins' exposure with incidence and prognosis of gastric cancer: An updated meta-analysis. Expert Rev Clin Pharmacol. 2022; 1-12 (Aug 15). Doi: 10.1080/17512433.2022.2112178

Key clinical point: Statin exposure reduces the risk for and improves the prognosis of gastric cancer.

Major finding: The statin-exposed vs -nonexposed population showed a significantly reduced incidence (odds ratio [OR] 0.78; P < .001) and improved prognosis (OR 0.78; P = .002) of gastric cancer.

Study details: This was a meta-analysis of 19 studies that analyzed the correlation between statin exposure and the occurrence and progression of gastric cancer.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Lou D et al. Association between statins' exposure with incidence and prognosis of gastric cancer: An updated meta-analysis. Expert Rev Clin Pharmacol. 2022; 1-12 (Aug 15). Doi: 10.1080/17512433.2022.2112178

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: Gastric Caner, October 2022
Gate On Date
Wed, 06/22/2022 - 12:15
Un-Gate On Date
Wed, 06/22/2022 - 12:15
Use ProPublica
CFC Schedule Remove Status
Wed, 06/22/2022 - 12:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article